Christi Shaw - Dec 13, 2023 Form 4 Insider Report for Beam Therapeutics Inc. (BEAM)

Role
Director
Signature
By: Christine Bellon, Attorney-in-fact
Stock symbol
BEAM
Transactions as of
Dec 13, 2023
Transactions value $
$0
Form type
4
Date filed
12/14/2023, 04:15 PM
Previous filing
May 15, 2023
Next filing
Jun 7, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BEAM Stock Option (Right to Buy) Award $0 +39K $0.00 39K Dec 13, 2023 Common Stock 39K $28.28 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests as to one-third of the shares subject to the option on the first anniversary of the date of grant and in equal monthly installments as to the remainder of the shares for two years thereafter, subject to the Reporting Person's continued service with the Company through each vesting date.